The Impact of Outpatient Laboratory Alerting Mechanisms in Patients with AKI. Issue 10 (28th October 2021)

• Record Type: Journal Article
• Authors: Tolan, Nicole V.; Ahmed, Salman; Terebo, Tolumofe; Virk, Zain M.; Petrides, Athena K.; Ransohoff, Jaime R.; Demetriou, Christiana A.; Kelly, Yvelynne P.; Melanson, Stacy E.F.; Mendu, Mallika L.
• Is Part Of: Kidney360. Volume 2:Issue 10(2021)
• Page Start: 1560
• Page End: 1568
• Publication Date: 2021-10-28
• Subjects: acute kidney injury and ICU nephrology -- acute kidney injury -- creatinine -- documentation -- laboratory alerts -- nephrotoxins -- outcomes -- outpatients; 616.61
• DOI: 10.34067/KID.0003312021
• Languages: English
• ISSNs: 2641-7650

Abstract

Visual Abstract: Abstract : Key Points: An AKI alert attached to increasing creatinine results improved recognition of AKI and reduced the time to obtain a follow-up creatinine. The additive intervention of an email alert to the ordering provider increased the discontinuation of nephrotoxins. Background: AKI is an abrupt decrease in kidney function associated with significant morbidity and mortality. Electronic notifications of AKI have been utilized in patients who are hospitalized, but their efficacy in the outpatient setting is unclear. Methods: We evaluated the effect of two outpatient interventions: an automated comment on increasing creatinine results (intervention I; 6 months; n =159) along with an email to the provider (intervention II; 3 months; n =105), compared with a control (baseline; 6 months; n =176). A comment was generated if a patient's creatinine increased by >0.5 mg/dl (previous creatinine ≤2.0 mg/dl) or by 50% (previous creatinine >2.0 mg/dl) within 180 days. Process measures included documentation of AKI and clinical actions. Clinical outcomes were defined as recovery from AKI within 7 days, prolonged AKI from 8 to 89 days, and progression to CKD with in 120 days. Results: Providers were more likely to document AKI in interventions I ( P =0.004; OR, 2.80; 95% CI, 1.38 to 5.67) and II ( P =0.01; OR, 2.66; 95% CI, 1.21 to 5.81). Providers were also more likely to discontinue nephrotoxins in intervention II ( P <0.001; OR, 4.88; 95% CI, 2.27 to 10.50). The median time to follow-up creatinine trended shorter among patients with AKI documented (21 versus 42 days; P =0.11). There were no significant differences in clinical outcomes. Conclusions: An automated comment was associated with improved documented recognition of AKI and the additive intervention of an email alert was associated with increased discontinuation of nephrotoxins, but neither improved clinical outcomes. Translation of these findings into improved outcomes may require corresponding standardization of clinical practice protocols for managing AKI.